FDA oversight hearing
Executive Summary
Center for Biologics Evaluation & Research financial management issues will be topic of hearing before Rep. Barton's (R-Tex.) Commerce/Oversight Subcommittee scheduled for April 1 at 10:30 a.m. in Rayburn 2322